Market Research

Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. For more, visit: https://www.marketsandmarkets.com

Analytical Laboratory Services Market- Analysis, Industry Size, Opportunities and Forecast

According to the new market research report "Analytical Laboratory Services Market by Public Health Organization, - by types of services (Stability, Raw Material, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring, Bioanalytical Testing) - Forecast to 2021", published by MarketsandMarkets™, The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period.

 

 

Don’t miss out on business opportunities in Analytical Laboratory Services Market, visit: https://www.marketsandmarkets.com/requestsampleNew.asp?id=65590498

 

The overall market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.

 

However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support on analytical laboratory services.

 

Browse and in-depth TOC on "Analytical Laboratory Services Market"

37  - Tables

7 - Figures

68 - Pages

 

On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring.

 

Read More Report @ https://www.marketsandmarkets.com/PressReleases/analytical-laboratory-services.asp

 

Geographically, the market, by public health organization is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. The major share of this region can be attributed to the high expenditure on quality testing, strong regulatory scenario, increasing number of clinical trials, and the well-established federal testing laboratories in the region. Moreover, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. This can be attributed to the fast-growing pharmaceutical industry in this region, increased government expenditure on healthcare, increasing number of highly competitive and extremely fragmented pharmaceutical companies, and increased spending by governments to set up new laboratories in Asian countries.

 

To read research insights, visit: https://www.marketsandmarkets.com/Market-Reports/analytical-laboratory-services-market-65590498

 

The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period. The key trends for increase in market, by public health organization are the growing expenditure on drugs and medical devices by public health organizations, steps by the government to build up strong analytical testing abilities, increasing number of drug approvals and clinical trials, and rising demand for specialized analytical testing services. However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support

 

To know about the assumptions considered for the study, download the pdf brochure, visit:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65590498

Source: http://www.marketsandmarkets.com/Market-Reports/analytical-laboratory-services-market-65590498.html

Anatomic Pathology Market - Scope, Size, Share, Analysis, Statistics & Trends

The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021.

 

The increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure are the major factors driving the growth of this market.

Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

 

To know about the assumptions considered for the study, download the pdf brochure , here: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

 

Anatomic Pathology Market segmentation:

  • by Product & Service
  • by Application
  • by Region

The Major Players Operating in the Anatomic Pathology Market:

 

Key players operating in the market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

 

Geographical Detailed Analysis for Anatomic Pathology Market:

 

The anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this Anatomical pathology market.

 

Read More in Detailed (Anatomic Pathology Market):

 

 

 https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

Source: http://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

Anatomic Pathology Market - Scope, Size, Share, Analysis, Statistics & Trends

The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021.

 

 

The increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure are the major factors driving the growth of this market.

Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

 

To know about the assumptions considered for the study, download the pdf brochure , here: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

 

Anatomic Pathology Market segmentation:

  • by Product & Service
  • by Application
  • by Region

The Major Players Operating in the Anatomic Pathology Market:

 

Key players operating in the market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

 

Geographical Detailed Analysis for Anatomic Pathology Market:

 

The anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this Anatomical pathology market.

 

Read More in Detailed (Anatomic Pathology Market):

 

 

 https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

Source: http://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

Needle Free Injection System Market Size, Analysis, Growth, Forecast and Industry Trends

According to the new market research report "Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", published by MarketsandMarkets™, The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

 

Don’t miss out on business opportunities in Needle-Free Injection System Market @ https://www.marketsandmarkets.com/Market- Reports/needle-free-injection-system-market-165815861.html

 

Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.

 

Browse and in-depth TOC on "Needle-Free Injection System Market"

151 - Tables

33 - Figures

183 - Pages

 

The report segments the market based on product, technology, type, site of delivery, applications, end user and regions. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

 

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

 

The report "Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Browse 151 market data tables and 33 figures spread through 183 pages and in-depth TOC on “Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021”

 

Order a copy of “Needle-Free Injection System Market” research study @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

 

Source: http://www.marketsandmarkets.com/Market-Reports/healthcare-information-exchange-market-249987292.html

Needle Free Injection System Market Size, Analysis, Growth, Forecast and Industry Trends

According to the new market research report "Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", published by MarketsandMarkets™, The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

 

Don’t miss out on business opportunities in Needle-Free Injection System Market @ https://www.marketsandmarkets.com/Market- Reports/needle-free-injection-system-market-165815861.html

 

Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.

 

Browse and in-depth TOC on "Needle-Free Injection System Market"

151 - Tables

33 - Figures

183 - Pages

 

The report segments the market based on product, technology, type, site of delivery, applications, end user and regions. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

 

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

 

The report "Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Browse 151 market data tables and 33 figures spread through 183 pages and in-depth TOC on “Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021”

 

Order a copy of “Needle-Free Injection System Market” research study @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

 

Source: http://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

Wireless Health Market Research Report, Market size, Growth, Analysis and forecast

The global wireless health market is projected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1% during the forecast period of 2015 to 2020.

 

 

The market is expected to witness the highest growth in the Asia-Pacific region in the coming years. Growth in the Asia-Pacific region can be attributed to factors such as increasing population, growing internet penetration, rising medical tourism, increasing government initiatives for eHealth, and growing demand for quality healthcare.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=551

Wireless health market segmentation:

 

 

  • Basis of components
  • Basis of technology
  • Basis of applications
  • Basis of end users
  • Basis of region

The Major Players Operating in the Wireless health market:

 

Allscripts Healthcare Solutions, Inc. (U.S.), AT &T, Inc. (U.S.), Cerner Corporation (U.S.), Omron Corporation (U.S.), Philips Healthcare (U.S.), Verizon Communications, Inc. (U.S.), Qualcomm, Inc. (U.S.), Aerohive Networks, Inc.(U.S.), Vocera Communications, Inc. (U.S.), and Alcatel-Lucent (U.S.) are some of the key players in the wireless health market worldwide.

 

The Major Players Operating in the Wireless health market:

 

Federal mandates such as Meaningful Use Stage II and growing adoption of wireless health devices among the elderly and patients suffering from chronic illnesses are some of the factors driving the growth of the wireless health market.

 

The global wireless market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America accounts for the largest share of the market, followed by Europe and Asia-Pacific. The large share of the North American wireless health market can primarily be attributed to the federal mandates in the U.S. and rising digital health measures in Canada. The Asia-Pacific region is estimated to grow rapidly during the forecast period due to rising internet penetration, growing medical tourism, and increasing government initiatives for eHealth.

 

Read More in Detailed (Wireless health market):

 

 

https://www.marketsandmarkets.com/PressReleases/wireless-health.asp

Health Information Exchange Market – Industry Analysis, Size, Share, Strategies and Forecast

The health information exchange market is projected to reach USD 1,545.0 million by 2020 from USD 990.6 million in 2015, at a CAGR of 9.3% during the forecast period.

Federal mandates like Meaningful use, growing patient-centric approach in healthcare delivery, increasing EHR adoption rate, and need to curtail healthcare cost are some of the key factors driving the growth of market.
Health information exchange (HIE) involves the electronic movement of health-related information among organizations according to nationally recognized standards. HIE aims to facilitate the access and retrieval of clinical data to provide safer, timelier, efficient, effective, equitable, patient -centered care.

 

Download PDF Brochure: https://www.marketsandmarkets.com/PressReleases/healthcare-information-exchange.asp

 

Health information exchange Market segmentation:

 

  • based on products
  • based on diseases
  • based on techniques
  • based on end users
  • based on regions

The Major Players Opearting in the Health information exchange Test Market:

 

Key players in this market include Allscripts Healthcare Solutions, Inc. (U.S.), Relayhealth Corporation (U.S.), Infor, Inc. (U.S.), Cerner Corporation (U.S.), and eClinicalWorks (U.S.) among others. These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

 

Geographical Detailed Analysis for Health information exchange Market:

 

In 2015, North America is poised to account for the largest share of the HIE market, followed by Europe and Asia-Pacific. However, the Asia-Pacific region is slated to grow at the highest CAGR during the forecast period. The large share of the North American health information exchange market can primarily be attributed to the federal mandates in the U.S., rising number of accountable care organizations’ ACO’s as end users for HIE platforms in the U.S., Canada’s efforts to enhance healthcare delivery, and digital health measures in Canada.

 

Allscripts Healthcare Solutions, Inc. (U.S.), RelayHealth Corporation (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Infor, Inc. (U.S.), Optum, Inc. (U.S.), Epic Corporation Inc. (U.S.), Orion Health (New Zealand) are some of the key players in the health information exchange market worldwide.

 

Read More in Detailed (Health information exchange Market): https://www.marketsandmarkets.com/PressReleases/healthcare-information-exchange.asp

Source: http://www.marketsandmarkets.com/PressReleases/healthcare-information-exchange.asp

Digital Therapeutics Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast

The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics.

 

However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.

 

Download PDF Brochure: https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

 

Digital Therapeutics Market segmentation:

 

  • based on products
  • based on diseases
  • based on techniques,
  • based on end users
  • based on regions. 

The Major Players Opearting in the Digital Therapeutics Market:

 

Key players in the digital therapeutics market include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), Canary Health Inc. (U.S.), Mango Health, Inc. (U.S.), and Physitrack Limited (U.K.). Click Therapeutics, Inc. (U.S.), Pear Therapeutics, Inc., (U.S.), Akili Interactive Labs, Inc. (U.S.) and Wellthy Therapeutics Pvt. Ltd (India) are some of the emerging players in this market.

 

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

 

Geographical Detailed Analysis for Digital Therapeutics Market:

 

The global digital therapeutics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market by the end of 2016. This large share can be attributed to various factors, including growing incidence of chronic diseases, government initiatives to support technological advancements in the field of digital therapeutics, and a growing influx of new startup companies in the market.

 

Prominent players in the digital therapeutics market include Proteus Digital Health, Inc. (U.S.), Omada Health Inc. (U.S.), WellDoc Inc. (U.S.), Livongo Health (U.S.), Noom Inc. (U.S.), Ginger.io Inc. (U.S.), Propeller Health (U.S.), 2Morrow Inc. (U.S.), Canary Health Inc. (U.S.), and Mango Health, Inc. (U.S.).

 

Read More in Detailed (Digital Therapeutics Market):

https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

Source: http://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

Cell Therapy Market Size, Share, Trends, Growth, Report Value | Industry Report

The global cell therapy technologies market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period.

 Factors such as rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are driving the growth of this market.

 

China, India, Japan, Korea, and Brazil are emerging markets for cell therapy instruments. These markets boast comparatively lenient standards and government regulations as opposed to developed markets in North America and the EU, and thus offer significant growth potential for providers. However, the high cost of cell-based research and the low success rate is expected to restrain market growth to some extent during the forecast period.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21333497

 

The global cell therapy technologies market segmentation:

 

  • cell processing
  • cell preservation
  • distribution And handling
  • cell process monitoring and quality control

Key Market Players

 

Key players in this cell therapy technologies market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).

 

Thermo Fisher was the largest player in the cell therapy technologies market in 2017. In order to maintain its position in the market and further expand its product portfolio, the company focuses on the strategies of product launches, acquisitions, and expansions. Merck holds the second position in the cell therapy technologies market. The company focuses on collaborations, agreements, and acquisitions to enhance its market position.

 

Geographical Detailed Analysis for the cell therapy instruments market :

 

 

The market, by region, is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2018. The large share of this regional segment can primarily be attributed to the high burden of chronic diseases and increasing R&D activities in pharmaceutical and biotechnology industries.

 

The market is dominated by players such as Beckman Coulter, Inc. (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT, Inc. (US), and Thermo Fisher Scientific, Inc. (US).

 

Read More in Detailed (cell therapy instruments market):

 

https://www.marketsandmarkets.com/PressReleases/cell-therapy-technologies.asp

Source: http://www.marketsandmarkets.com/PressReleases/cell-therapy-technologies.asp

Bioinformatics Market worth $23.89 billion in 2027, at CAGR of 14.5%

The global bioinformatics market is projected to reach $23.89 billion in 2027 from $8.09 billion in 2018, at CAGR of 14.5%.

 

Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39

 

 

Global bioinformatics market segmentation:

  • Based on product and service
  • Based on applications
  • Based on sector

The Major Players Opearting in the Bioinformatics Market Key Players

 

Key players that provide bioinformatics products and services are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US) and DNASTAR (US). These players focus on both organic and inorganic growth strategies such as product launches, partnerships, and agreements to maintain and enhance their market share in the market.

 

One of the major factors restraining market growth is the lack of well-defined standards and common formats for data integration. Most of the research institutes have their own exclusive identifiers, indexing schemes, and data formats. As data models change frequently, the data integration process becomes difficult. This may limit the growth of the market to a certain extent.

 

Geographical Detailed Analysis for Bioinformatics Market :

 

 

North America is expected to account for the largest share of the market. The large share of North America is attributed to the continued funding from the government and private sectors for life sciences research.

 

 One of the major factors restraining market growth is the lack of well-defined standards and common formats for data integration. Most of the research institutes have their own exclusive identifiers, indexing schemes, and data formats. As data models change frequently, the data integration process becomes difficult. This may limit the growth of the market to a certain extent.

 

Read More in Detailed (Bioinformatics Market):

 

https://www.marketsandmarkets.com/PressReleases/bioinformatics-market.asp

Source: http://www.marketsandmarkets.com/PressReleases/bioinformatics-market.asp

Bioinformatics Market worth $23.89 billion in 2027, at CAGR of 14.5%

The global bioinformatics market is projected to reach $23.89 billion in 2027 from $8.09 billion in 2018, at CAGR of 14.5%.

 

Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39

 

 

Global bioinformatics market segmentation:

 

  • Based on product and service
  • Based on applications
  • Based on sector

The Major Players Opearting in the Bioinformatics Market Key Players

 

Key players that provide bioinformatics products and services are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US) and DNASTAR (US). These players focus on both organic and inorganic growth strategies such as product launches, partnerships, and agreements to maintain and enhance their market share in the market.

 

One of the major factors restraining market growth is the lack of well-defined standards and common formats for data integration. Most of the research institutes have their own exclusive identifiers, indexing schemes, and data formats. As data models change frequently, the data integration process becomes difficult. This may limit the growth of the market to a certain extent.

 

Geographical Detailed Analysis for Bioinformatics Market :

 

 

North America is expected to account for the largest share of the market. The large share of North America is attributed to the continued funding from the government and private sectors for life sciences research.

 One of the major factors restraining market growth is the lack of well-defined standards and common formats for data integration. Most of the research institutes have their own exclusive identifiers, indexing schemes, and data formats. As data models change frequently, the data integration process becomes difficult. This may limit the growth of the market to a certain extent.

 

Read More in Detailed (Bioinformatics Market):

 

 ttps://www.marketsandmarkets.com/PressReleases/bioinformatics-market.asp

 

Source: http://www.marketsandmarkets.com/PressReleases/bioinformatics-market.asp

Infectious Disease Diagnostics Market worth $25.43 billion by 2027

The report "Infectious Disease Diagnostics Market by Product & Service(Assay, Kit & Reagent, Instruments), Disease Type(Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology(Immunodiagnostics, PCR, NGS), End User(Hospital, Research Institute) - Global Forecast to 2027", The global infectious disease diagnostics market is expected to reach USD 25.43 billion by 2027 from USD 15.57 billion in 2018, at a CAGR of 5.6%. The increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics are some the factors driving the growth of this market.

 

Browse 85 market data Tables and 35 Figures spread through 170 Pages and in-depth TOC on "Infectious Disease Diagnostics Market by Product & Service(Assay, Kit & Reagent, Instruments), Disease Type(Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology(Immunodiagnostics, PCR, NGS), End User(Hospital, Research Institute) - Global Forecast to 2027"
https://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html

 

North America dominated the market in 2018

In 2018, North America accounted for the largest share of the global infectious disease diagnostics market. This largest share is attributed to the presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.

The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMérieux (France), Bio-Rad (US), and Roche (Switzerland).

Don’t miss out on business opportunities in Infectious Disease Diagnostics Market . Speak to our analyst and gain crucial industry insights that will help your business grow.

Source: http://www.marketsandmarkets.com/PressReleases/infectious-disease-diagnostics.asp

Needle Free Injection System Market Size, Analysis, Growth, Forecast and Industry Trends

According to the new market research report "Needle-Free Injection System Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", published by MarketsandMarkets™, The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.

 

Don’t miss out on business opportunities in Needle-Free Injection System Market @ https://www.marketsandmarkets.com/Market- Reports/needle-free-injection-system-market-165815861.html

 

 

Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.

 

Browse and in-depth TOC on "Needle-Free Injection System Market"

151 - Tables

33 - Figures

183 - Pages

 

The report segments the market based on product, technology, type, site of delivery, applications, end user and regions. Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors. The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.

 

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

 

The report "Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021", The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Browse 151 market data tables and 33 figures spread through 183 pages and in-depth TOC on “Needle Free Injection Systems Market by Product (Fillable, Prefilled), by Technology (Jet, Spring, Laser, Vibration), Usability (Reusable, Disposable), Type of Medication (Liquid, Depot), Delivery Site (Intramuscular, Subcutaneous) - Forecasts to 2021”

 

https://www.marketsandmarkets.com/Market-Reports/needle-free-injection-system-market-165815861.html

 

Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.

 

Order a copy of “Needle-Free Injection System Market” research study @https://www.marketsandmarkets.com/PressReleases/needle-free-injection-system.asp

 

Source: http://www.marketsandmarkets.com/Market-Reports/needle-free-injection-system-market-165815861.html

Western Blotting Market - Industry Trends, Growth & Forecast

According to the new market research report "Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021", published by MarketsandMarkets™, The western blotting market is projected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).

 

Get Sample Copy for more Professional and Research Insight @ https://www.marketsandmarkets.com/ResearchInsight/western-blotting-market.asp

The report segments market based on product, application, end user, and region.

The western blotting market, by product is segmented into instruments and consumables. Consumables segment is expected to account for the largest share of the market, by product in 2016. This segment is also expected to grow at the highest CAGR during the forecast period. The western blotting instruments are further classified into gel electrophoresis instruments, blotting systems, and imagers. The blotting systems segment is expected to account for the largest share of western blotting instruments market, by type in 2016. However, the imagers segment is expected to grow at the highest CAGR during the forecast period (2016-2021).

 

Browse and in-depth TOC on "Western Blotting Market"

121 - Tables

40 - Figures

169  - Pages

 

The growth of the overall market can be attributed to the increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, and growing proteomics market are key factors driving the demand for western blotting instruments and consumables, increasing demand for personalized medicine, and new product launches are some of the other factors driving the growth of this market.

 

Order a copy of “ Western Blotting Market ” research study  @https://www.marketsandmarkets.com/PressReleases/western-blotting.asp

 

Based on the end user, the western blotting market is segmented into academic & research institutes, diagnostic centers, pharmaceutical & research laboratories, diagnostic centers, forensic laboratories, and contract research organizations (CROs), among others. In 2016, the academic & research institutes segment is expected to command the largest share of the global market, by end user. However, the pharmaceutical & biotechnology companies segment is projected to grow at the highest CAGR from 2016 to 2021.

 

In the coming years, the western blotting market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to increasing government interest in biomedical & biotechnology industry in China, government initiatives supported by funding in Japan, growing funding for agriculture research in India, increasing diagnosis and related funding in Australia, and growing prevalence of herpes simplex virus (HSV) in southeast Asia.

 

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/Market-Reports/western-blotting-market-235810711.html

Source: http://www.marketsandmarkets.com/Market-Reports/western-blotting-market-235810711.html

Digital Therapeutics Market Industry Analysis, Size, Share, Growth, Trends and Forecast

According to the new market research report " Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

 

Get Sample Copy for more Professional and Technical insights at : https://www.marketsandmarkets.com/ResearchInsight/digital-therapeutics-market.asp

 

 

The factors driving market growth include growing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. However, factors such as lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the digital therapeutics market growth.

 

Browse and in-depth TOC on "Digital Therapeutics Market"

148  - Tables

36  - Figures

 

 Order a copy of “Digital Therapeutics Market Size & Share | Industry Analysis” research study at:

https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

The digital therapeutics market is highly fragmented, diversified, and increasingly competitive, with a large number of small players competing for market space, including startup firms. Each segment has different market players and market leaders. For instance, the prediabetes market was led by Omada in 2015. Omada Health is a leading provider of digital therapeutics for preventable type 2 diabetes and heart disease. Omada’s product portfolio consists of ‘Prevent’, an online diabetes prevention program. The company has succeeded in securing heavy investments which it channelizes into the development, enhancement, and commercialization of its product.

 

Make an Inquiry Prior To Purchase this research study at: https://www.marketsandmarkets.com/Market-Reports/digital-therapeutics-market-51646724.html

Source: http://www.marketsandmarkets.com/Market-Reports/digital-therapeutics-market-51646724.html

Healthcare Information Exchange Market| Statistics & Trends | MarketsandMarkets™

According to the new market research report "Health Information Exchange Market by Set Up Type (Public, Private), Type (Pull, Push), Implementation Model (Federated, Hybrid), Application (Web Portal, Secure Messaging), Solution Type (Portal, Platform Centric), & End Users - Global Forecast to 2020", published by MarketsandMarkets™, The health information exchange market is projected to reach USD 1,545.0 million by 2020 from USD 990.6 million in 2015, at a CAGR of 9.3% during the forecast period.

 

Don’t miss out on business opportunities in Health Information Exchange Market

 

Federal mandates like Meaningful use, growing patient-centric approach in healthcare delivery, increasing EHR adoption rate, and need to curtail healthcare cost are some of the key factors driving the growth of market.

 

Health information exchange (HIE) involves the electronic movement of health-related information among organizations according to nationally recognized standards. HIE aims to facilitate the access and retrieval of clinical data to provide safer, timelier, efficient, effective, equitable, patient -centered care. HIE enables collaboration between healthcare stakeholders, cuts down on administrative tasks, and eventually provides greater transparency in the field of healthcare. HIE is an ever-changing concept. Continuously changing technological and regulatory environment consistently evolves the HIE space.

 

Get Sample Copy for more Professional and Technical insights at : https://www.marketsandmarkets.com/Market-Reports/healthcare-information-exchange-market-249987292.html

 

Browse and in-depth TOC on "Health Information Exchange Market"

78  - Tables

41 - Figures

201 - Pages

 

This increasing usage of electronic health record as well as web portals for easy retrieval of patient information is driving the market for web portal development application segment

 

Web portal development

 

Over the years, web portals have been used in healthcare organizations to schedule appointments, register patients, and send secure email to providers. They are also used to provide laboratory results, refill prescription requests, and maintain personal health records. According to Stage 2 of Meaningful Use, patients should have access to view and download electronic copies of their own medical records. Web portals help in retrieving patient information, in an easier and efficient manner as compared to obta ining health records manually.

 

Workflow management

 

HIEs and EHRs help healthcare professionals in health management and enable better decision-making for enhanced patient care. HIEs also facilitate reduction in duplicative treatment, thus avoiding additional expenses.

Make an Inquiry Prior To Purchase this research study at:

https://www.marketsandmarkets.com/PressReleases/healthcare-information-exchange.asp

Source: http://www.marketsandmarkets.com/Market-Reports/healthcare-information-exchange-market-249987292.html